Skip to main content

Find Clinical Trials

Home
Conditions
HRD Cancer

Clinical trial condition

HRD Cancer

Explore clinical trials studying HRD Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

HRD Cancer trial results

Not Yet Recruiting

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

NCT06614751

Conditions: Advanced Cancer, BRCA Mutation, Breast Cancer, +44 more
Locations: Peking University Cancer Hospital and Institute Beijing, Beijing Municipality, China

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijjing, Beijing Municipality, China

View Trial Details

Completed

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors

NCT04826341

Conditions: Advanced Solid Tumors, HRD Cancer, SCLC
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details